Evidence map›Paper›PMID 40911665›Full record

ArticleScience advances2025

Synaptic imbalance and increased inhibition impair motor function in SMA.

Emily V Fletcher, Joshua I Chalif, Travis M Rotterman, John G Pagiazitis, Meaghan Van Alstyne, Nandhini Sivakumar, Danny Florez-Paz, Joseph E Rabinowitz, Livio Pellizzoni, Francisco J Alvarez and 1 more

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Emily V FletcherCenter for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA.ORCID 0000-0002-9786-4221
Joshua I ChalifCenter for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA.ORCID 0000-0003-1769-5120
Travis M RottermanDepartment of Cell Biology, Emory University, Atlanta, GA 30322, USA.ORCID 0000-0003-0044-7948
John G PagiazitisCenter for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA.ORCID 0009-0007-3660-7268
Meaghan Van AlstyneCenter for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA.ORCID 0000-0002-9939-5705
Nandhini SivakumarCenter for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA.
Danny Florez-PazCenter for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA.ORCID 0000-0001-5832-089X
Joseph E RabinowitzDepartment of Pharmacology, Center of Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Livio PellizzoniCenter for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA.ORCID 0000-0002-9168-5628
Francisco J AlvarezDepartment of Cell Biology, Emory University, Atlanta, GA 30322, USA.ORCID 0000-0001-7011-3244
George Z MentisCenter for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA.ORCID 0000-0002-4610-2016

Funding

Mechanisms of Central Synaptic Dysfunction in SMAR01NS078375 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI George Z Mentis · 2012 to 2026
$6.6M
DEVELOPMENT OF SYNAPTIC INPUTS ON SPINAL INTERNEURONSR01NS047357 · NINDS · WRIGHT STATE UNIVERSITY · PI ALVAREZ, FRANCISCO J · 2004 to 2025
$6.4M
RNA-Mediated Mechanisms of Motor System Dysfunction in Spinal Muscular AtrophyR01NS102451 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Livio Pellizzoni · 2017 to 2026
$3.9M
Mechanisms of synaptic loss by the classical complement pathway in motor circuit development and diseaseR01AA027079 · NIAAA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MENTIS, GEORGE Z · 2018 to 2022
$3.2M
Essential role of Stasimon in motor circuit development and diseaseR01NS114218 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PELLIZZONI, LIVIO · 2020 to 2024
$2.9M
Cellular and Neuronal Circuit Mechanisms Involved in Locomotor ActivityR01NS125362 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI George Z Mentis · 2023 to 2026
$2.5M
Mechanisms and Therapeutic Targeting of Motor Neuron Death in SMAR01NS116400 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PELLIZZONI, LIVIO · 2020 to 2024
$2.3M
NIAAA NIH HHS R01 AA027079NINDS NIH HHS R01 NS047357NINDS NIH HHS R01 NS078375NINDS NIH HHS R01 NS102451NINDS NIH HHS R01 NS114218NINDS NIH HHS R01 NS116400NINDS NIH HHS R01 NS125362
6 · The paper itself

Abstract

Movement is executed through balanced excitation-inhibition in spinal motor circuits. Short-term perturbations in one type of neurotransmission are homeostatically counteracted by the opposing type, but prolonged excitation-inhibition imbalance causes dysfunction at both single neuron and circuit levels. However, whether dysfunction in one or both types of neurotransmission leads to pathogenicity in neurodegenerative diseases characterized by select synaptic deficits is not known. Here, we used functional, morphological, and viral-mediated approaches to uncover the pathogenic contribution of unbalanced excitation-inhibition in a mouse model of spinal muscular atrophy (SMA). We show that vulnerable SMA motor circuits fail to respond homeostatically to reduced excitation and instead increase inhibition. This imposes an excessive burden on motor neurons and further restricts their recruitment. Reducing inhibition genetically or pharmacologically improves neuronal function and motor behavior in SMA mice. Thus, the disruption of excitation-inhibition homeostasis is a major maladaptive mechanism that diminishes the capacity of premotor commands to recruit motor neurons and elicit muscle contractions in SMA.

Indexed as

Motor NeuronsMuscular Atrophy, SpinalSynapsesSynaptic TransmissionAnimalsDisease Models, AnimalMiceMotor Activity

Identifiers

PMID40911665
PMCPMC12412662

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.